121 related articles for article (PubMed ID: 18794660)
1. Weight gain and first-generation antipsychotics: experience from a developing country.
Yoon CK
J Clin Psychopharmacol; 2008 Oct; 28(5):574-6. PubMed ID: 18794660
[No Abstract] [Full Text] [Related]
2. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
3. Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective study.
Rettenbacher MA; Baumgartner S; Eder-Ischia U; Edlinger M; Graziadei I; Hofer A; Huber R; Hummer M; Kemmler G; Weiss E; Fleischhacker WW
J Clin Psychopharmacol; 2006 Oct; 26(5):500-3. PubMed ID: 16974192
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study].
Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C
Recenti Prog Med; 2009 Feb; 100(2):103. PubMed ID: 19350804
[No Abstract] [Full Text] [Related]
5. Relation between weight gain and clinical improvement: is there a metabolic threshold for second generation antipsychotics?
Sharma E; Rao NP; Venkatasubramanian G; Behere RV; Varambally S; Sivakumar PT; Gangadhar BN
Psychiatry Res; 2011 Mar; 186(1):155. PubMed ID: 20691482
[No Abstract] [Full Text] [Related]
6. Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
Keltner NL
Perspect Psychiatr Care; 2006 Aug; 42(3):204-7. PubMed ID: 16916424
[No Abstract] [Full Text] [Related]
7. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
Carpiniello B; Corda E; Maccioni R; Pinna F
Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
[TBL] [Abstract][Full Text] [Related]
8. Study focuses in on potential cause of antipsychotic-induced diabetes.
O'Neill MF
Drug News Perspect; 2005 Oct; 18(8):481-2. PubMed ID: 16391716
[TBL] [Abstract][Full Text] [Related]
9. Interventions to reduce weight gain in schizophrenia.
Faulkner G; Cohn T; Remington G
Schizophr Bull; 2007 May; 33(3):654-6. PubMed ID: 17449900
[No Abstract] [Full Text] [Related]
10. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
Chen CK; Chen YC; Huang YS
Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
[TBL] [Abstract][Full Text] [Related]
11. Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis.
Verma S; Liew A; Subramaniam M; Poon LY
Aust N Z J Psychiatry; 2009 Sep; 43(9):812-7. PubMed ID: 19670054
[TBL] [Abstract][Full Text] [Related]
12. Follow-up interventions in persons with schizophrenia and metabolic syndrome.
Kølbæk P; Schiöth E; Aagaard J; Munk-Jørgensen P
Aust N Z J Psychiatry; 2014 Nov; 48(11):1059-60. PubMed ID: 25277542
[No Abstract] [Full Text] [Related]
13. Effects of risperidone on lipid profile.
Khalili H; Dashti-Khavidaki S; Okhovatpour H; Ghaeli P
Ann Pharmacother; 2007 May; 41(5):899-900. PubMed ID: 17426072
[No Abstract] [Full Text] [Related]
14. Choosing between atypical antipsychotics: weighing the risks and benefits.
Bailey KP
Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S2-S11. PubMed ID: 12046019
[No Abstract] [Full Text] [Related]
15. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
Hrdlicka M; Zedkova I; Blatny M; Urbanek T
Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512
[TBL] [Abstract][Full Text] [Related]
16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
17. Is there an anti-fat bias among schizophrenia patients?
Pierson KE
Obesity (Silver Spring); 2006 Dec; 14(12):2305. PubMed ID: 17189559
[No Abstract] [Full Text] [Related]
18. Use of atypical antipsychotics in children: balancing safety and effectiveness.
Kohlstadt I; Vitiello B
Am Fam Physician; 2010 Mar; 81(5):585. PubMed ID: 20187594
[No Abstract] [Full Text] [Related]
19. Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis.
Souza RP; De Luca V; Muscettola G; Rosa DV; de Bartolomeis A; Romano Silva M; Kennedy JL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1848-53. PubMed ID: 18793692
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic-induced weight gain in patients with schizophrenia.
Llewellyn DJ; Naughton F
JAMA; 2008 Apr; 299(16):1898-9; author reply 1899-900. PubMed ID: 18430905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
